ID   2-27-Ad
AC   CVCL_IY39
SY   2-27 Ad
DR   Wikidata; Q54582924
RX   CelloPub=CLPUB00384;
RX   PubMed=6310010;
RX   PubMed=6324641;
CC   Virology: EBV-negative.
CC   Derived from site: In situ; Pharynx, nasopharynx; UBERON=UBERON_0001728.
CC   Cell type: Epithelial cell of nasopharynx; CL=CL_1001573.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
RX   CelloPub=CLPUB00384;
RA   Furukawa M., Umeda R., Hatano M.;
RT   "Transfer of EBV (Epstein-Barr virus) genome from lymphoblastoid cells
RT   to established epithelial cells derived from human tissues.
RT   Experimental studies on the viral etiology of nasopharyngeal carcinoma
RT   (NPC) related to EBV infection.";
RL   Kanazawa Daigaku Juzen Igakkai Zasshi 84:190-210(1975).
//
RX   PubMed=6310010; DOI=10.1017/S0022215100094883;
RA   Takimoto T., Morishita K., Furukawa M., Umeda R., Hatano M.;
RT   "Establishment of Epstein-Barr virus (EBV) infection in epithelial
RT   cells derived from the nasopharynx by cell fusion.";
RL   J. Laryngol. Otol. 97:719-726(1983).
//
RX   PubMed=6324641; DOI=10.1177/000348948409300213;
RA   Takimoto T., Furukawa M., Hatano M., Umeda R.;
RT   "Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid
RT   cells.";
RL   Ann. Otol. Rhinol. Laryngol. 93:166-169(1984).
//